Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT03381755
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT03381755
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03381755. Randomized; single masking; primary purpose prevention. Start 2018-01-01 (actual); primary completion 2019-12-14 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- half-dose ticagrelor
- Intervention (Drug)
- standard-dose ticagrelor
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
Record details
- Record id
cardio:ct-nct03381755- Content hash
c51de68bc29daf93fbcd19a070ec5073e8b5beb9f6b8b5fba849d123adf82353